Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
about
UKPDS and beyond: into the next millennium. United Kingdom Prospective Diabetes Study.Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.Challenges in optimal metabolic control of diabetes.Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus.Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.Prescribing pattern of antidiabetic drugs and achievement of glycemic control in T2DM patients tertiary care hospital in North India
P2860
Q34164138-58A0A499-BA6B-4C41-B8B9-9FD55227F49EQ34344990-216F06D0-C8F2-4236-A637-6C9ABBF40DE6Q34906359-66746B75-3033-4B72-B18E-DD36B0B645DBQ37427914-74312859-B112-4337-88A3-96C98DB0405FQ38191195-B940EC14-0738-41DE-B2ED-25F4274E6638Q44699316-4F3708AF-241C-4FAA-9605-5BD1FD444BBDQ58164411-7BFAE4C4-CC65-4106-85F9-2B2A9712091D
P2860
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
@ast
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
@en
type
label
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
@ast
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
@en
prefLabel
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
@ast
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
@en
P1433
P1476
Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
@en
P2093
P356
10.2165/00002018-199921010-00002
P577
1999-07-01T00:00:00Z
P6179
1048040805